Savara submits BLA for MOLBREEVI with FDA priority review set for August
Go back to Savara submits BLA for MOLBREEVI with FDA priority review set for August| (NASDAQ: SVRA) | Delayed: 5.60 +0.04 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.56 | 52 Week High | $ | |||
| Open | $5.69 | 52 Week Low | $ | |||
| Day High | $5.72 | P/E | N/A | |||
| Day Low | $5.52 | EPS | $ | |||
| Volume | 1,608,567 | |||||
